Where can PARP inhibitors be used
How can germline mutations distinguish risk for lethal and indolent prostate cancer?
Genetic testing for breast and ovarian cancer: tackling the challenges to availability
The impact of preoperative malnutrition on surgery outcome in cancer patients
Innovations in ovarian cancer treatment: PARP inhibitors